Cite

HARVARD Citation

    Arόstegui, J. et al. (n.d.). THU0554 Final Analysis of Study of Efficacy and Safety of Canakinumab in Active Hyper-IGD Syndrome. Annals of the rheumatic diseases. p. 401. [Online]. 
  
Back to record